Search Page
Save citations to file
Email citations
On or after July 28, sending email will require My NCBI login.
Learn more about this and other changes coming to the email feature.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2023 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Lancet Oncol. 2021 Feb;22(2):277-288. doi: 10.1016/S1470-2045(20)30591-X. Epub 2020 Dec 22.
Lancet Oncol. 2021.
PMID: 33357510
Free PMC article.
Clinical Trial.
Benefit From Fractionated Dose-Dense Chemotherapy in Patients With Poor Prognostic Ovarian Cancer: ICON-8 Trial.
Colomban O, Clamp A, Cook A, McNeish IA, You B.
Colomban O, et al.
JCO Clin Cancer Inform. 2023 Apr;7:e2200188. doi: 10.1200/CCI.22.00188.
JCO Clin Cancer Inform. 2023.
PMID: 37075255
Free PMC article.
Item in Clipboard
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.
James EC, Dunn D, Cook AD, Clamp AR, Sydes MR.
James EC, et al.
Trials. 2020 Sep 17;21(1):802. doi: 10.1186/s13063-020-04718-z.
Trials. 2020.
PMID: 32943106
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.